Phase 2 Study of Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children

Trial Profile

Phase 2 Study of Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2016

At a glance

  • Drugs Nimotuzumab (Primary) ; Temozolomide
  • Indications Brain cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Mar 2016 Planned End Date changed from 1 Aug 2016 to 1 Aug 2017, as reported by ClinicalTrials.gov.
    • 31 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Jan 2017, as reported by ClinicalTrials.gov.
    • 16 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top